Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy

J Wu, Y Tang, X Liang - OncoTargets and therapy, 2018 - Taylor & Francis
J Wu, Y Tang, X Liang
OncoTargets and therapy, 2018Taylor & Francis
Vascular normalization is a new concept of targeting angiogenesis to restore vessel
structure and function and to increase blood perfusion and delivery of drugs. It has been
confirmed that vascular normalization can decrease relapse and benefit other cancer
therapy, including chemotherapy, radiotherapy, and immune cell therapy. The key point of
this therapy is to inhibit pro-angiogenic factors and make it be balanced with anti-angiogenic
factors, resulting in a mature and normal vessel characteristic. Vascular endothelial growth …
Vascular normalization is a new concept of targeting angiogenesis to restore vessel structure and function and to increase blood perfusion and delivery of drugs. It has been confirmed that vascular normalization can decrease relapse and benefit other cancer therapy, including chemotherapy, radiotherapy, and immune cell therapy. The key point of this therapy is to inhibit pro-angiogenic factors and make it be balanced with anti-angiogenic factors, resulting in a mature and normal vessel characteristic. Vascular endothelial growth factor (VEGF) is a key player in the process of tumor angiogenesis, and inhibiting VEGF is a primary approach to tumor vessel normalization. Herein, we review newly uncovered mechanisms governing angiogenesis and vascular normalization of cancer and place emphasis on targeting VEGF pathway to normalize the vasculature. Also, important methods to depress VEGF pathway and make tumor vascular are discussed.
Taylor & Francis Online